Dr. Adam Lerner, MD

Dr. Lerner practices at Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System.

Dr. Lerner's NPI, 1063460087, was assigned on May 4, 2006. Dr. Lerner graduated from Yale University School of Medicine in 1983. Dr. Lerner holds Massachusetts license 55760.

Dr. Lerner's primary practice is Boston Medical Center, at 1 Boston Medical Center Place, Boston, MA 02118 in Suffolk County. The practice phone is (617) 638-8000.

Dr. Lerner's primary practice is Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System. The medical group on file is Boston University Medical Group (Boston University Internal Medicine Associates). Dmand AI also links Dr. Lerner to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lerner practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Lerner's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Lerner is licensed in Massachusetts.

CMS data shows 307 Medicare services from Dr. Lerner across 6 procedure codes in 2024, for 148 Medicare patients. Medicare paid $27,224 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 148 Medicare patients who saw Dr. Lerner in 2024. The largest group is 65 to 74, with 63 patients. 69% of them have high blood pressure, and 55% have high cholesterol. 64% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lerner's median patient age at 60, with 53% women.

In 2024, Dr. Lerner wrote 847 Medicare Part D claims for 111 patients. 50% of them were for generic drugs. CMS names the drug for 662 of them, across 25 drugs with 11 or more claims each, at $4,152,582 in total drug cost. In 2023, CMS named 801 claims across 28 drugs.

Dr. Lerner accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 45 papers to Dr. Lerner, published from 2010 to 2025. 2016 was the busiest year, with 3. The most frequent topics are Lymphoma, T-Cell, Cutaneous, Antibiotics, Antineoplastic and Cardiac Surgical Procedures. Dr. Lerner has published most often in J Cardiothorac Vasc Anesth. Dr. Lerner's most frequent co-authors are John M. Sloan, MD, Vaishali Sanchorawala, MD and Madeleine Duvic, MD.

Dmand AI links Dr. Lerner to 6 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Delirium, Melanoma and Nevi and Melanomas. National Cancer Institute (NCI) sponsors the most, 3.

CMS Open Payments shows 8 general payments to Dr. Lerner from 5 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $298. It also lists 2 research payments totaling $3,595 from 2016 to 2017.

Dr. Lerner graduated from Yale University School of Medicine in 1983.